Assessment of cardiovascular risk in population groups. Comparison of Score system and Framingham in hypertensive patients;Valoración de riesgo cardiovascular en grupos de población. Comparación de los sistemas Score y Framingham en pacientes hipertensos

Revista Clinica Espanola

Volumn 206, Issue 4, 2006, Pages 182-187

  Coin Aguilar J ^a   Hernandiz Martinez A ^a   Rodriguez Padial L ^b   Zamorano Gomez J L ^c   Aristegui Urrestarazu R ^d   Armada Pelaez B ^d   Aguilar Llopis, A ^a   Masramon Morell, X ^e  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d PFIZER INC   (United States)

^e Euroclin   (Spain)

Author keywords

Cardiovascular risk; Coronary risk; Framingham formula; Regional differences in cardiovascular risk; Risk factors in ACs; Score formula

Indexed keywords

AMLODIPINE;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY RISK; DOSE RESPONSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; SPAIN; STATISTICAL SIGNIFICANCE;

EID: 33744467940     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086798     Document Type: Article

References (31)

1. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factors categories. Circulation. 1998;97:1837-47.
2. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
3. Regidor E, Rodríguez C, Gutiérrez-Fisac JL. Indicadores de salud. Tercera evaluación en España del programa regional europeo Salud para todos. Madrid: Ministerio de Sanidad y Consumo; 1995.
4. Villar F, Banegas JR, Rodríguez Artalejo F, del Rey J. Mortalidad de causa cardiovascular en España y sus Comunidades Autónomas (1975-1992). Med Clin. 1998;110:321-7.
5. Boix R, Medrano MJ, Almazán J. Actualización de la mortalidad por enfermedades cardiovasculares arterioscleróticas, enfermedad cerebrovascular y enfermedad isquémica del corazón. Bol Epidemiol Sem. 2000;8:77-80.
6. Boix R, Almazán J, Medrano MJ. Mortalidad por insuficiencia cardiaca en España 1997-1998. Rev Esp Cardiol. 2002;55:219-26.
7. Cosín J, Asin E, Marrugat J, Elosua R, Aros F, de los Reyes M, et al. Prevalence of angina pectoris. Eur J Epidemiol. 1999;15:323-30.
8. López-Bescos L, Cosín J, Elosua R, Cabadés A, de los Reyes M, Aros F, et al. Prevalencia de la angina y factores de riesgo cardiovascular en las distintas Comunidades Autónomas: estudio PANES. Rev Esp Cardiol. 1999; 52:1045-56.
9. Fiol M, Cabadés A, Sala J, Marrugat J, Elosua R, Vega G, et al. Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda). Rev Esp Cardiol. 2001;54:443-52.
10. Moreno R. Manejo del infarto agudo de miocardio en España. Diferencias interregionales en la actualidad según el registro IBERICA. Rev Esp Cardiol. 2001;54:419-21.
11. Cosín Aguilar J, Rodríguez Padial L, Zamorano Gómez JL, Arístegui Urrestarazu R, Armada Peláez B, Hernándiz Martínez A, et al. Diferencias de riesgo coronario en pacientes hipertensos de las Comunidades Autónomas. Estudio CORONARIA. Rev Clin Esp. 2004;12:10-7.
12. SAS Institute Inc, SAS/STAT® User's Guide, Version 6; 4th edition. Volumes 1 and 2. Cary, North Carolina: SAS Institute, Inc; 1989.
13. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-87.
14. Greenland P, La Bree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-5.
15. Thompson GR, Partridge J. Coronary calcification score: the coronary-risk impact factor. Lancet. 2004;363:557-9.
16. Brown BG, Morse J, Zhao XQ, Cheung M, Marino E, Albers JJ. Electron-bean tomography coronary calcium scores are superior to Framingham risk variables for predicting the measured proximal stenosis burden. Am J Cardiol. 2001;88:23E-6E.
17. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826-33.
18. Kieltyka L, Urbina EM, Tang R, Bond MG, Srinavasan SR, Berenson GS. Framingham risk score is related to carotid artery intima-media thickness in both in white and black young adults: The Bogalusa heart study. Atherosclerosis. 2003;170:125-30.
19. Ridker PM, Cook N. Clinical usefulness of very low levels of c-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004;109:1955-9.
20. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of c-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003;108:161-5.
21. Yamasshina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res. 2003;26:615-22.
22. Janket SJ, Qvarnstrom M, Meurman JH, Baird AE, Nuutinen P, Jones JA. Asymptotic dental score and prevalent coronary heart disease. Circulation. 2004;109:1095-100.
23. Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20-4.
24. Thomseen TF, McGee D, Davidsen M, Jorgensen T. Across-validation of risk scores for coronary heart disease mortality based on data from the glostrup Population Studies and Framingham Heart Study. Int J Epidemiol. 2002,31:817-22.
25. de Visser CL, Bilo HJ, Thomsen TF, Gronier KH, Meyboom-de Jong B. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population. J Intern Med. 2003;253:553-62.
26. Marrugat J, Solanas P, D'Agostino, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003,56:253-61.
27. Wihelmsen L, Wedel H, Conroy R, Fitzgerald T. The Swedish Score chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases. Lakartdningen. 2004;13;1798-801.
28. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003;327:1267.
29. Averina M, Nilssen O, Brenn T, Brox J, Kalinin AG, Arkhipovsky VL. High cardiovascular mortality in Russia cannot be explained by the classical risk factors. The Arkhangelsk Study 2000. Eur J Epidemiol. 2003;18:871-8.
30. Brucket E, Thomas D, Emmerich J, Blin P, Bichon L, Amelineau E. Impact of an information campaign on cardiovascular risk factors. 5-year results at the study town Epernon. Presse Med. 1999;28:517-22.
31. Lee JD, Morrissey JR, Patel V. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (practice of Evidence-based Medicine). Curr Med Res Opin. 2004;20:765-72.